ArticleBJU international2018

Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Yair Lotan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.